FDC informed that the drug maker has received final approval from United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Cefixime 400 mg tablets.
Innoviva (INVA) announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica for the commercialization of Zevtera, an advanced-generation cephalosporin ...